Biotech Ingredients Market

Biotech Ingredients Market - Global Forecast to 2023

Report Code: UC 1982 Aug, 2024, by

Biotech ingredients are large and complex drugs that are structurally identical to compounds found in natural organisms. These medical drugs are produced using complex biotechnological processes, such as genetic engineering and hybridoma technology as well as biopharmaceutical techniques such as recombinant DNA technology, gene transfer, and antibody production methods. Manufacturing of biotech APIs involves the use of microorganisms or genetically modified organisms, or substances produced by living organisms (like enzymes). Biopharmaceuticals include complex proteins such as antibodies, nucleic acids (like DNA and RNA), or antisense oligonucleotides that are produced by methods which are different from direct extraction from natural, non-engineered organisms.

The growth in this market is mainly driven by the increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in manufacturing, growing importance of generics, rapidly increasing geriatric population, and increasing uptake of biopharmaceuticals.

The report segments the biotech ingredients market based on type, product, and expression system. On the basis of type, the market can be categorized into two segments, namely, innovative biotech APIs and generic biotech APIs (also referred to as biosimilars). On the basis of product, the market is classified into monoclonal antibodies, hormones, vaccines, cytokines, fusion proteins, therapeutic enzymes, and blood factors. On the basis of expression system, biotech ingredients can be categorized into mammalian expression systems, microbial expression systems, yeast expression systems, and other expression systems.

This report is a comprehensive study of current trends in the market, industry growth drivers, and restraints. These markets are given analysis at regional level to provide exhaustive value market analysis for the years 2016, 2017, 2018, and forecast to 2023. Each market is comprehensively analyzed at a granular level by region (North America, Europe, Asia Pacific, and RoW) to provide in-depth information on the global scenario.

The key players in the global biotech ingredients market are Pfizer Inc. (U.S.), Novartis International AG (Switzerland), Merck & Co. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Mylan, Inc. (U.S.), Boehringer Ingelheim (Germany), Sanofi (France), AbbVie (U.S.), Eli Lilly and Company (U.S.), AstraZeneca plc (U.K.), Bristol-Myers Squibb (U.S.), and GlaxoSmithKline plc (U.K.).

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 Biotech Ingredients Market, By Type
    6.1 Introduction
    6.2 Innovative Biotech Apis 
    6.3 Biosimilars 

7 Biotech Ingredients Market, By Product
    7.1 Introduction
    7.2 Monoclonal Antibodies 
    7.3 Vaccines 
    7.4 Hormones and Growth Factors 
    7.5 Cytokines
    7.6 Fusion Proteins
    7.7 Therapeutic Enzymes
    7.8 Blood Factors

8 Biotech Ingredients Market, By Expression System
    8.1 Introduction
    8.2 Mammalian Expression Systems
    8.3 Microbial Expression Systems
    8.4 Yeast Expression Systems
    8.5 Plant Expression Systems
    8.6 Insect Expression Systems

9 Biotech Ingredients Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 UK
           9.3.2 Germany
           9.3.3 France
           9.3.4 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape
     10.1 Overview
     10.2 Key Player Ranking Analysis (2017)
     10.3 Competitive Scenario
             10.3.1  Agreements, Partnerships, Collaborations, and Contracts
             10.3.2  Expansions
             10.3.3  Acquisitions
             10.3.4  Product Launches

11 Company Profiles (Overview, Products and Services, Financials, Strategy & Development)
     11.1 Introduction
     11.2 Pfizer
     11.3 Novartis International 
     11.4 Sanofi
     11.5 Boehringer Ingelheim 
     11.6 Bristol-Myers Squibb 
     11.7 Teva Pharmaceutical Industries 
     11.8 Eli Lilly 
     11.9 Glaxosmithkline 
     11.10 Merck 

12 Appendix

The Segmentation Given May Change Depending on Research Findings.
The List of Companies May Change as Per Further Research Findings. Top 10 Companies Will Be Profiled in This Section. Details on Overview, Products, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies
Years Considered for the Study Would Be Historical Year 2016, Base Year 2017, Estimated Year 2018, Forecast Period 2018 to 2023
The Market Tables Would Include Value Data in USD for the Years 2016, 2017, 2018 and Forecasted Value for 2023 Along With CAGR for the Period 2018-2023

Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
3 6 9 0 3  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
UC 1982
Available for Pre-Book
Choose License Type
Prebook Now
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Biotech Ingredients Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status Website Feedback